Frederick Driscoll

Insider Reports History

Entity
Individual
Signature
/s/ Christina Blakley, attorney-in-fact for Frederick Driscoll
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frederick Driscoll:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Renovacor, Inc. Chief Financial Officer Option 155K Mar 28, 2022 Direct
Cellectar Biosciences, Inc. Director Stock option (right to buy) 60K Jun 14, 2024 Direct
Cue Biopharma, Inc. Director Stock Option (right to buy) 24.4K Jan 2, 2024 Direct
MEI Pharma, Inc. Director Stock Option (Right to Buy) 10K Sep 29, 2023 Direct
Flexion Therapeutics Inc Chief Financial Officer Common Stock 0 $8.50 Nov 19, 2021 Direct
Flexion Therapeutics Inc Chief Financial Officer Stock option (right to buy) 0 Nov 19, 2021 Direct

Insider Reports Filed by Frederick Driscoll

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLRB Cellectar Biosciences, Inc. Jun 14, 2024 1 $0 4 Jun 18, 2024 Director
CUE Cue Biopharma, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
MEIP MEI Pharma, Inc. Sep 29, 2023 1 $0 4 Oct 12, 2023 Director
CLRB Cellectar Biosciences, Inc. Jun 28, 2023 1 $0 4 Jun 28, 2023 Director
CUE Cue Biopharma, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
IVVD Invivyd, Inc. Oct 13, 2022 0 $0 3 Oct 13, 2022 Interim CFO
MEIP MEI Pharma, Inc. Jul 5, 2022 1 $0 4 Jul 7, 2022 Director
CLRB Cellectar Biosciences, Inc. Jun 24, 2022 1 $0 4 Aug 1, 2022 Director
RCOR Renovacor, Inc. Mar 28, 2022 1 $0 4 Mar 28, 2022 Chief Financial Officer
RCOR Renovacor, Inc. Mar 28, 2022 0 $0 3 Mar 28, 2022 Chief Financial Officer
CUE Cue Biopharma, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
FLXN Flexion Therapeutics Inc Nov 19, 2021 2 -$261K 4 Nov 19, 2021 Chief Financial Officer
CLRB Cellectar Biosciences, Inc. Sep 3, 2021 1 $20.2K 4 Sep 7, 2021 Director
MEIP MEI Pharma, Inc. Jul 1, 2021 1 $0 4 Jul 6, 2021 Director
CLRB Cellectar Biosciences, Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
FLXN Flexion Therapeutics Inc Jun 1, 2021 2 $0 4 Jun 3, 2021 Chief Financial Officer
FLXN Flexion Therapeutics Inc Jun 1, 2021 0 $0 3 Jun 3, 2021 Chief Financial Officer